Genetic Determinants of Cardiovascular Response to Coffee Drinking

Status Completed

Clinical Trial Summary

Cardiovascular and neuropsychologic effects of coffee are still debated. The precise mechanism underlying the actions of caffeine on the cardiovascular and neuropsychologic systems is incompletely understood and a considerable variability in the response to coffee drinking was observed, in part ascribable to a genetic trait.

The aim of the study is to evaluate acute cardiovascular and neuropsychologic effects of coffee and explore whether such effects are influenced by the genetic asset of caffeine metabolism (by a polymorphisms of cytochrome P450 1A2), adenosine metabolism (by polymorphisms of adenosine receptor and adenosine monophosphate deaminase) or catecholamine receptors (by polymorphisms of adrenergic receptors).

Clinical Trial Description

Coffee is among the most widely consumed beverages worldwide. Despite the relationship between coffee consumption and the incidence of cardiovascular disease has been studied extensively, the effects of this drink on the cardiovascular apparatus and its role as a risk factor for coronary heart disease are still debated. Moreover, the effect of coffee on attention, sleep changes, anxiety and panic disorders was studied but a great variability was observed.

Many of the known or suspected cardiovascular and neuropsychologic effects of coffee have been attributed to caffeine. The main mechanism of action of caffeine is to antagonize adenosine receptors; a secondary effect is the inhibition of phosphodiesterases, with the subsequent accumulation of cyclic adenosine monophosphate and a intensification of the effects of catecholamines.

It is also well known that there is a considerable variability in the cardiovascular and neuropsychologic response to coffee drinking, explaining the inconsistency between different effects observed in the various studies. This variability may have a genetic basis.

The aim of the study is to evaluate acute cardiovascular and neuropsychologic effects of coffee and explore whether such effects are influenced by the genetic asset of caffeine metabolism (by a polymorphisms of cytochrome P450 1A2), adenosine metabolism (by polymorphisms of adenosine receptor and adenosine monophosphate deaminase) or catecholamine receptors (by polymorphisms of adrenergic receptors). ;

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)

Related Conditions & MeSH terms

Caffeine

Clinical Trial Details

NCT number	NCT01330680
Study type	Interventional
Source	G. d'Annunzio University
Contact
Status	Completed
Phase	N/A
Start date	September 2004
Completion date	September 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06038903` - The Turkish Version Of The Brief-Caffeine Expectancy Questionnaire
Completed	`NCT02900261` - Study on Sodium and Caffeine in Children and Adolescents
Completed	`NCT03850275` - The Effects of e+Shots Energy Beverage on Mental Energy	N/A
Completed	`NCT01924481` - Effects of a Cocoa Shot on the Human Brain	N/A
Completed	`NCT00184912` - The Effect of Caffeine on Ischemic Preconditioning	N/A
Completed	`NCT03859882` - Protocol PERCAF 2018	N/A
Completed	`NCT02832401` - The Impact of Caffeine on Cognition in Schizophrenia	N/A
Completed	`NCT04560595` - Remote Guided Caffeine Reduction	N/A
Recruiting	`NCT05503732` - Effects of Energy Drinks on Sleep and Cardiovascular Health	N/A
Not yet recruiting	`NCT05521386` - The Effects of Caffeine on Heart Rate and Heart Rate Variability	N/A
Completed	`NCT06039358` - Effects of Caffeine Ingestion on the Biomechanics of Healthy Young Subjects	N/A
Active, not recruiting	`NCT04547868` - Can Coffee/Caffeine Improve Post-Operative Gastrointestinal Recovery	N/A
Completed	`NCT05559372` - Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes	N/A
Completed	`NCT01783561` - Early Versus Routine Caffeine Administration in Extremely Preterm Neonates	Phase 4
Completed	`NCT04852315` - Acute Caffeine Ingestion on Futsal Performance	N/A
Completed	`NCT05975489` - Genetics in the Effect of Caffeine on Fat Oxidation	N/A
Recruiting	`NCT03298347` - Caffeine for Preterm Infants With Apnea of Prematurity(AOP)	N/A
Completed	`NCT01435486` - Caffeine Citrate for the Treatment of Apnea Associated With Bronchiolitis in Young Infants	N/A
Completed	`NCT04869176` - Effect of Caffeine on Heart Rate Variability in Newborns	N/A
Completed	`NCT04585854` - Effect of Caffeine on Myocardial Oxygenation	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.